Multiple sclerosis in Tayside, Scotland: Detection of clusters using a spatial scan statistic

Multiple Sclerosis

Volumn 11, Issue 4, 2005, Pages 403-408

  Donnan, Peter T ^a   Parratt, John D E ^a   Wilson, Sally V ^a   Forbes, Raeburn B ^b   O'Riordan, Jonathan I ^a   Swingler, Robert J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Cluster analysis; Multiple sclerosis; Spatial epidemiology; Spatial scan statistic

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; INCIDENCE; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PATHOGENESIS; PERIODICITY; POPULATION DENSITY; POPULATION RESEARCH; REGISTER; RURAL AREA; SEX DIFFERENCE; SOCIAL ISOLATION; UNITED KINGDOM;

ADULT; AGE OF ONSET; CLUSTER ANALYSIS; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MODELS, STATISTICAL; MULTIPLE SCLEROSIS; REGISTRIES; SCOTLAND; SEX CHARACTERISTICS;

EID: 22144457400     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1191oa     Document Type: Article

References (33)

1. Kurtzke JF. The epidemiology of multiple sclerosis. In Raine CS, McFarland HF, Tourtellotte WW eds. Multiple sclerosis. Clinical and pathogenetic basis, first edition. London: Chapman and Hall, 1997, 105-107.
2. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol 1979; 5: 6-21.
3. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology. J Epidemiol Community Health 1980; 34: 229-39.
4. Kurtzke JF, Gudmundsson KR, Bergmann S. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology 1982; 32: 143-50.
5. Benedikz J, Magnusson H, Guthmundsson G. Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Ann Neurol 1994; 36: S175-79.
6. Poser CM, Hibberd PL, Benedikz J, Gudmundsson G. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology 1988; 7: 168-80.
7. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998; 64: 730-35.
8. Binzer M, Forsgren L, Holmgren G, Drugge U, Fredrikson S. Familial clustering of multiple sclerosis in a northern Swedish rural district. J Neurol Neurosurg Psychiatry 1994; 57: 497-99.
9. Eastman R, Sheridan J, Poskanzer DC. Multiple sclerosis clustering in a small Massachusetts community with possible common exposure 23 years before onset. N Engl J Med 1973; 10: 793-94.
10. Jaworski MD, Slater JD, Severini A, Henning KR, Mansour G, Mehta JG et al. Unusual clustering of diseases in a Canadian Old Colony (Chortitza) Mennonite kindred and community. Can Med Assoc J 1988; 138: 1017-25.
11. McDougall EM. Multiple sclerosis in research workers studying swayback lambs: an updated report. J Neurol Neurosurg Psychiatry 1985; 48: 859-65.
12. Stein EC, Schiffer RB, Hall WJ, Young N. Multiple Sclerosis and the workplace: report of an industry based cluster. Neurology 1987; 37: 1672-77.
13. Larsen JP, Riise T, Nyland H Kvale G, Aarli JA. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurol Scand 1985; 71: 390-95.
14. Neutel CI, Walter SD, Mousseau G. Clustering during childhood of multiple sclerosis patients. J Chronic Dis 1977; 30: 217-24.
15. Poskanzer DC, Walker AM, Prenney LB, Sheridan JL. The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset. Neurology 1981; 31: 708-13.
16. Riise T, Gronning M, Klauber MR, Barrett-Connor E, Nyland H, Albrektsen G. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991; 133: 932-39.
17. Knox G. The detection of space-time interaction. Appl Stat 1964; 13: 25-29.
18. Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 1999; 246: 1033-40.
19. Kulldorff M, Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med 1995; 14: 799-810.
20. Hjalmars U, Kulldorff M, Gustafsson G, Nagarwalla N. Childhood leukaemia in Sweden: using GIS and a spatial scan statistic for cluster detection. Stat Med 1996; 15: 707-15.
21. Kulldorff M, Feuer EJ, Miller BA, Freedman LS. Breast cancer in northeastern United States: A geographical analysis. Am J Epidemiol 1997; 146: 161-70.
22. Kulldorff M. A spatial scan statistic. Commun Stat Theory Methods 1997; 26: 1481-96.
23. Forbes RB. Capture-recapture methods in epidemiological surveys. University of Dundee, Dundee, 1999.
24. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995; 17: 243-64.
25. Forbes RB, Swingler RJ. Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology. Am J Epidemiol 1999; 149: 1016-24.
26. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
27. McLoone P. Carstairs codes for Scottish postcodes from the 1991 census. Glasgow: Public Health Research Unit, University of Glasgow, 1991.
28. Turnbull BW, Iwano EJ, Burnett WS, Howe HL, Clark LC. Monitoring for clusters of disease: application to leukemia incidence in upstate New York. Am J Epidemiol 1990; 132: S136-43.
29. Kulldorff M, Rand K, Gherman G, Williams G, DeFranscesco D. SaTScan v2.1: software for the spatial and space-time scan statistics. Bethesda, MD: National Cancer Institute, 1998.
30. Alter M, Zhang ZX, Davanipour Z, Sabel E, Zibulewski J, Schwartz G et al. Multiple sclerosis and childhood infections. Neurology 1986; 36: 1386-89.
31. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986; 49: 1115-24.
32. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083-88.
33. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003; 289: 1533-36.